Owen Hughes's Net Worth

$10.6 Million

Estimate Recalculated Jul 15, 2025 01:01PM EST

Who is Owen Hughes

Owen Hughes has an estimated net worth of $10.6 Million. This is based on reported shares across multiple companies, which include PARDES BIOSCIENCES, INC., Cullinan Management, Inc., Radius Health, Inc., Translate Bio, Inc., XOMA Corp, Ikena Oncology, Inc., and C4 Therapeutics, Inc..

SEC CIK

Owen Hughes's CIK is 0001575933

Past Insider Trading and Trends

2023 was Owen Hughes's most active year for acquiring shares with 10 total transactions. Owen Hughes's most active month to acquire stocks was the month of January. 2021 was Owen Hughes's most active year for disposing of shares, totalling 7 transactions. Owen Hughes's most active month to dispose stocks was the month of August. 2021 saw Owen Hughes paying a total of $52,500.00 for 593,832 shares, this is the most they've acquired in one year. In 2021 Owen Hughes cashed out on 208,295 shares for a total of $1,134,680.00, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

PARDES BIOSCIENCES, INC.

Investor
Updated Dec 30, 2021
Form 4/A
Dec 30, 2021
30.00K
Options
Dec 23
Form 4
Dec 28, 2021
52.50K
Options
Dec 23
Form 3
Feb 16, 2021
Showing 3 results

Cullinan Management, Inc.

President and CEO
Updated Jan 14, 2021
Form 4
0.50%
2.50K
$21.00
$52.50K
Jan 14, 2021
506.23K
Purchase
Jan 12
Form 4
433.33K
Jan 11, 2021
433.33K
Grant
Jan 07
Form 3
Jan 07, 2021
503.73K
Showing 3 results

Radius Health, Inc.

Investor
Updated Aug 15, 2022
Form 4
-100.00%
-64.54K
$6.40
-$318.29K
Aug 15, 2022
Disposition
Aug 15
Form 4
95.98%
15.50K
Jan 25, 2022
31.65K
Grant
Jan 14
Form 4
145.54%
15.50K
Feb 23, 2021
26.15K
Grant
Feb 22
Form 4
40.00K
Jan 25, 2021
40.00K
Grant
Jan 21
Form 4
-20.52%
-2.75K
$17.95
-$49.36K
Feb 28, 2020
10.65K
Sale
ScheduledFeb 26
Form 4
196.20%
15.50K
Feb 24, 2020
23.40K
Grant
Feb 20
Form 4
-23.30%
-2.40K
$22.22
-$53.33K
Apr 18, 2019
7.90K
Sale
ScheduledApr 16
Form 4
322.92%
15.50K
Feb 26, 2019
20.30K
Grant
Feb 22
Form 4
Feb 13, 2019
4.80K
Options
Feb 13
Form 4
13.60K
Feb 15, 2018
13.60K
Grant
Feb 13
Form 4
27.50K
Feb 22, 2017
27.50K
Grant
Feb 17
Form 4
27.50K
Jun 02, 2016
27.50K
Grant
May 24
Form 4
27.50K
Feb 12, 2016
27.50K
Grant
Feb 10
Form 4
15.00K
May 26, 2015
15.00K
Grant
May 07
Form 4
30.00K
Dec 19, 2014
30.00K
Grant
Dec 17
Form 4
32.89K
Jun 09, 2014
32.89K
Grant
Jun 05
Form 3
May 03, 2013
Showing 17 results

Translate Bio, Inc.

Investor
Updated Sep 14, 2021
Form 4
-100.00%
-125.80K
$38.00
-$1.13M
Sep 14, 2021
Sale
Sep 14
Form 4
20.00K
Jun 16, 2021
20.00K
Grant
Jun 16
Form 4
18.90K
Jun 16, 2020
18.90K
Grant
Jun 16
Form 4
18.90K
Jun 19, 2019
18.90K
Grant
Jun 18
Form 3
Jun 27, 2018
29.86K
Showing 5 results

XOMA Corp

Chief Executive Officer
Updated Jan 10, 2024
Form 4
275.00K
Jan 10, 2024
275.00K
Grant
Jan 08
Form 4
40.00%
1.00K
$13.83
$13.83K
Oct 04, 2023
5.50K
Purchase
Oct 02
Form 4
2.50K
$14.43
$36.08K
Sep 27, 2023
4.50K
Purchase
Sep 25 - Sep 26
Form 4
2.00K
$23.63
$47.26K
May 25, 2023
2.00K
Purchase
May 23 - May 24
Form 3
Jan 06, 2023
Form 4
175.00K
Jan 05, 2023
175.00K
Grant
Jan 03
Showing 6 results

Ikena Oncology, Inc.

Investor
Updated Jun 10, 2024
Form 4
17.52K
Jun 10, 2024
17.52K
Grant
Jun 07
Form 4
17.52K
Jun 13, 2023
17.52K
Grant
Jun 09
Form 4
35.04K
Dec 19, 2022
35.04K
Grant
Dec 15
Form 3
Dec 19, 2022
Showing 4 results

C4 Therapeutics, Inc.

Investor
Updated Jun 21, 2024
Form 4
32.50K
Jun 21, 2024
32.50K
Grant
Jun 20
Form 4
52.00K
Nov 20, 2023
52.00K
Grant
Nov 16
Form 3
Nov 20, 2023
Showing 3 results